Irritable Bowel Syndrome News and Research

Latest Irritable Bowel Syndrome News and Research

Emisphere Technologies announces commercial launch of oral Eligen B12

Emisphere Technologies announces commercial launch of oral Eligen B12

Napo Pharmaceuticals hosts educational panel to address global health and environment

Napo Pharmaceuticals hosts educational panel to address global health and environment

Neurocrine Biosciences enters into an amendment to its facility lease agreement

Neurocrine Biosciences enters into an amendment to its facility lease agreement

Research confirms that probiotic bacteria promotes health and boosts immune system

Research confirms that probiotic bacteria promotes health and boosts immune system

Retinoic acid may provide relief for ulcerative colitis

Retinoic acid may provide relief for ulcerative colitis

Meridian Bioscience Europe to distribute the BÜHLMANN Calprotectin test in Italy

Meridian Bioscience Europe to distribute the BÜHLMANN Calprotectin test in Italy

Antidepressant amitriptyline works just as well as placebo for children with gastrointestinal disorders

Antidepressant amitriptyline works just as well as placebo for children with gastrointestinal disorders

Mayo Clinic scientists conduct clinical study on functional dyspesia patients

Mayo Clinic scientists conduct clinical study on functional dyspesia patients

Neurocrine and Kingsbridge Capital sign CEFF agreement

Neurocrine and Kingsbridge Capital sign CEFF agreement

Lexicon initiates Phase 2 clinical trial of LX4211 in patients with type 2 diabetes mellitus

Lexicon initiates Phase 2 clinical trial of LX4211 in patients with type 2 diabetes mellitus

Innovative treatments for bowel dysfunction

Innovative treatments for bowel dysfunction

Phase 2b clinical trial results of Dextofisopam to treat irritable bowel syndrome announced

Phase 2b clinical trial results of Dextofisopam to treat irritable bowel syndrome announced

Phase 3 results of TARGET 1 and TARGET 2 clinical trials released

Phase 3 results of TARGET 1 and TARGET 2 clinical trials released

European MAA for lubiprostone withdrawn by Sucampo Pharma Europe

European MAA for lubiprostone withdrawn by Sucampo Pharma Europe

Ono Pharmaceutical secures exclusive rights to develop and commercialize asimadoline in Japan

Ono Pharmaceutical secures exclusive rights to develop and commercialize asimadoline in Japan

FDA accepts for filing Salix Pharmaceuticals' NDA for rifaximin tablets

FDA accepts for filing Salix Pharmaceuticals' NDA for rifaximin tablets

SQI Diagnostics continues discussions with the FDA to market it's SQiDworks Diagnostics Platform in the US

SQI Diagnostics continues discussions with the FDA to market it's SQiDworks Diagnostics Platform in the US

Study looks at imipramine in the treatment of irritable bowel syndrome

Study looks at imipramine in the treatment of irritable bowel syndrome

Tips to avoid heat stroke

Tips to avoid heat stroke

Cause of colic

Cause of colic